Mainz Biomed NV (Mainz Biomed NV) EV-to-EBIT : -0.75 (As of Jun. 04, 2024)

Mainz Biomed NV EV-to-EBIT Chart

Mainz Biomed NV Quarterly Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EV-to-EBIT	Get a 7-Day Free Trial								-3.45	-3.17	-2.57	-1.76	-0.98

Competitive Comparison of Mainz Biomed NV's EV-to-EBIT

For the Diagnostics & Research subindustry, Mainz Biomed NV's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Mainz Biomed NV's EV-to-EBIT Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Mainz Biomed NV's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Mainz Biomed NV's EV-to-EBIT falls into.

Mainz Biomed NV EV-to-EBIT Calculation

Mainz Biomed NV's EV-to-EBIT for today is calculated as:

Mainz Biomed NV's current Enterprise Value is $19.37 Mil.
Mainz Biomed NV's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-25.70 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mainz Biomed NV  (NAS:MYNZ) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Mainz Biomed NV's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Mainz Biomed NV's Enterprise Value for the quarter that ended in Dec. 2023 was $24.90 Mil.
Mainz Biomed NV's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-25.70 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mainz Biomed NV EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Mainz Biomed NV's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Mainz Biomed NV (Mainz Biomed NV) Business Description